Literature DB >> 20811167

Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage.

G Parenti1, P C Cecchi, B Ragghianti, A Schwarz, F Ammannati, P Mennonna, A Di Rita, P Gallina, N Di Lorenzo, P Innocenti, G Forti, A Peri.   

Abstract

BACKGROUND: Subarachnoid hemorrhage (SAH) is a potential cause of hypopituitarism. Most of the studies regarding the relationship between SAH and anterior pituitary function were retrospective and hormonal assessment was performed several months after SAH. AIM: To prospectively evaluate the prevalence of anterior pituitary hormone deficiencies in the acute phase after spontaneous SAH and their possible correlation with clinical and radiological parameters.
METHODS: Pituitary function was tested in 60 patients within 72 h after spontaneous SAH.
RESULTS: 56.9% of the patients showed at least one anterior pituitary hormone deficiency: gonadotropin and GH secretion failure represented the most prevalent hormonal deficiencies (33.3 and 22.0%, respectively), whereas ACTH and TSH deficiency was less frequent (7.1 and 1.8%, respectively). With the exception of secondary hypogonadism, the prevalence of other pituitary hormone deficiencies is in agreement with previous studies, which evaluated pituitary function on longterm follow up after SAH. No correlation was found between hypopituitarism and clinical status, as assessed with Hunt-Hess and Glascow Coma Scales. Moreover, no correlation was found between hypopituitarism and bleeding severity evaluated with Fisher's scale.
CONCLUSIONS: We demonstrated a high prevalence of anterior pituitary hormone deficiencies acutely after SAH. Although part of GH and gonadotropin deficiencies might be a consequence of functional alteration due to SAH itself, the finding of low cortisol levels in this stressful condition strongly suggests the presence of true hypocortisolism. Therefore, an evaluation of pituitary function shortly after SAH might be useful to identify a subset of patients who deserve a more accurate follow-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811167     DOI: 10.1007/BF03347460

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.

Authors:  E Nieschlag; R Swerdloff; H M Behre; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; J E Morley; C Schulman; C Wang; W Weidner; F C W Wu
Journal:  Eur Urol       Date:  2005-07       Impact factor: 20.096

Review 2.  Pituitary insufficiency.

Authors:  S W Lamberts; W W de Herder; A J van der Lely
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

4.  Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report.

Authors:  D F Kelly; I T Gonzalo; P Cohan; N Berman; R Swerdloff; C Wang
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

5.  High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage.

Authors:  Ioanna Dimopoulou; Andreas T Kouyialis; Marinella Tzanella; Apostolos Armaganidis; Nikolaos Thalassinos; Damianos E Sakas; Stylianos Tsagarakis
Journal:  Stroke       Date:  2004-10-21       Impact factor: 7.914

6.  Evaluation of pituitary and thyroid hormones in patients with subarachnoid hemorrhage due to ruptured intracranial aneurysm.

Authors:  Paola Mangieri; Kunio Suzuki; Moema Ferreira; Lucília Domingues; Luiz Augusto Casulari
Journal:  Arq Neuropsiquiatr       Date:  2003-04-16       Impact factor: 1.420

7.  Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury.

Authors:  Gianluca Aimaretti; Maria Rosaria Ambrosio; Carolina Di Somma; Alessandra Fusco; Salvatore Cannavò; Maurizio Gasperi; Carla Scaroni; Laura De Marinis; Salvatore Benvenga; Ettore Carlo degli Uberti; Gaetano Lombardi; Franco Mantero; Enio Martino; Giulio Giordano; Ezio Ghigo
Journal:  Clin Endocrinol (Oxf)       Date:  2004-09       Impact factor: 3.478

Review 8.  The altered adrenal axis and treatment with glucocorticoids during critical illness.

Authors:  Dieter Mesotten; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-09

9.  High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event.

Authors:  Fatih Tanriverdi; Ahmet Turan Dagli; Zuleyha Karaca; Kursad Unluhizarci; Ahmet Selcuklu; Felipe F Casanueva; Fahrettin Kelestimur
Journal:  Clin Endocrinol (Oxf)       Date:  2007-07-30       Impact factor: 3.478

Review 10.  Neuroendocrinology and pathophysiology of the stress system.

Authors:  C A Stratakis; G P Chrousos
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

View more
  11 in total

1.  Three years prospective investigation of pituitary functions following subarachnoid haemorrhage.

Authors:  Z Karaca; F Tanriverdi; A T Dagli; A Selcuklu; F F Casanueva; K Unluhizarci; F Kelestimur
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

2.  Treatment of endocrine disorders in the neuroscience intensive care unit.

Authors:  Janice J Hwang; David Y Hwang
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

Review 3.  Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis.

Authors:  Chiara Robba; Susanna Bacigaluppi; Nicola Bragazzi; Andrea Lavinio; Mark Gurnell; Federico Bilotta; David K Menon
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

4.  Diagnosis and Management of Hyponatremia in Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Neena I Marupudi; Sandeep Mittal
Journal:  J Clin Med       Date:  2015       Impact factor: 4.241

Review 5.  Hypopituitarism after subarachnoid haemorrhage, do we know enough?

Authors:  Ladbon Khajeh; Karin Blijdorp; Sebastian Jcmm Neggers; Gerard M Ribbers; Diederik Wj Dippel; Fop van Kooten
Journal:  BMC Neurol       Date:  2014-10-14       Impact factor: 2.474

6.  The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study.

Authors:  Sumithra Giritharan; Joanna Cox; Calvin J Heal; David Hughes; Kanna Gnanalingham; Tara Kearney
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

7.  High Prolactin Level as a Predictor of Vasospasm in Aneurysmal Subarachnoidal Hemorrhage.

Authors:  Ilker Çöven; Atilla Kırcelli; Enes Duman; Huseyin Ulas Pınar; Betul Basaran
Journal:  Med Sci Monit       Date:  2017-08-08

8.  Impact of Thyroid Hormone Levels on Functional Outcome in Neurological and Neurosurgical Early Rehabilitation Patients.

Authors:  Melanie Boltzmann; Simone B Schmidt; Jens D Rollnik
Journal:  Biomed Res Int       Date:  2017-08-16       Impact factor: 3.411

Review 9.  Cortisol levels and the severity and outcomes of acute stroke: a systematic review.

Authors:  Amanda Jayne Barugh; Paul Gray; Susan Deborah Shenkin; Alasdair Maurice Joseph MacLullich; Gillian Elizabeth Mead
Journal:  J Neurol       Date:  2014-01-30       Impact factor: 4.849

10.  Neurosurgical Hyponatremia.

Authors:  Mark J Hannon; Christopher J Thompson
Journal:  J Clin Med       Date:  2014-10-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.